I commend her in her thoughtful approach to this issue, and for her leadership.
The Food and Drug Administration Safety and Innovation Act, FDASIA, was signed into law on July 9th, 2012.
The bill represents a bipartisan success, not only for our committee, but for Congress as a whole.
I think we have some real questions about the utilization--not the utilization, but the recording or the assessing of th...
I couldn't agree with him more. As a prosecutor for 18 years, a DAUS attorney, it is appalling to me what white-collar c...
I believe we, the American people, are due a report, whether that was a local issue or what issue it might have been, wh...
I am concerned that weakening of equipment maintenance standards could have some severe consequences for patient safety.
I would insist that the Attorney General's office with a vengeance go after these individuals, take everything that they...
Let me make a formal request that that inquiry be made, but more importantly, that that reimbursement structure be put i...
We convene this hearing of the subcommittee on Oversight and Investigations to gain a better understanding of the impact...
Inventors and companies should be encouraged to research and develop ideas, technologies, and products and be rewarded f...
Our purpose in holding this hearing is to learn more about a number of questionable practices that have recently prolife...
Let me state at the outset that a strong and fair patent system is essential to an innovative marketplace.
In a time of universal deceit, telling the truth is a revolutionary act.
At a time of universal deceit, telling the truth is a revolutionary act.
What does that mean, and how do we fix that or how do we improve that?
I wanted to pursue the line of questioning that goes to whether we keep or whether we do not keep the SPOT program.
I would like to have the opportunity, if we could, to have that discussion.
